Currently, these technologies are subject to the EU’s strict GMO regulation, making their commercialisation in the bloc ...

Q4 2024 Earnings Call Transcript March 20, 2025 Cibus, Inc. misses on earnings expectations. Reported EPS is $-0.87 EPS, ...

Founder, Chief Operating Officer, Director, Interim Chief Executive Officer; Cibus Inc Greg Gocal; Co-Founder, Executive Vice President, Chief Scientific Officer; Cibus Inc Laurence Alexander; Analyst ...

Discover how Cibus Inc (CBUS) is navigating financial challenges while making strides in gene-editing technology and market ...

EU countries have officially sealed their position on plans to loosen rules on the use of new genetic technologies, setting ...

Somewhat predictably, EFSA found "no new potential hazards, and thus, no new risks to humans, animals, or the environment are anticipated" from the use of these techniques in animals, beyond those ...

Legislation aims to adapt EU law to reflect scientific and technological progress, enabling the products of New Genomic Techniques (NGTs), such ...

Chandigarh: The Post Graduate Institute of Medical Education and Research (PGIMER) Chandigarh is working towards establishing ...

A three-year grant funded by Wisconsin Partnership Program, a grantmaking program within the University of Wisconsin School of Medicine and Public Health, is backing research into how the reduction of ...

Advancements in genome editing, particularly CRISPR, are reshaping precision biology, driving innovations in medicine, agriculture, and synthetic biology.